Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | RYTM | BMY | AMGN | GILD | VRTX |
| Company | Rhythm Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 37.83 | 47.93 | 265.64 | 67.01 | 394.19 |
| High | 38.90 | 48.41 | 265.92 | 67.02 | 396.14 |
| Low | 37.62 | 47.62 | 262.58 | 65.90 | 391.01 |
| Last | 38.11 | 48.30 | 262.75 | 66.16 | 393.48 |
| Change | -0.34 | +0.46 | -1.32 | -0.77 | +0.38 |
| % Change | -0.88% | +0.96% | -0.50% | -1.15% | +0.10% |
| Volume | 439,000 | 10,917,500 | 2,082,700 | 6,442,200 | 949,000 |
| 20-Day Average Volume | 534,710 | 11,419,555 | 2,201,900 | 6,214,910 | 909,480 |
| Previous Close | 38.45 | 47.84 | 264.07 | 66.93 | 393.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 40.72 | 50.99 | 272.96 | 70.21 | 406.59 |
| 20-Day Raw Stochastic | 8.16% | 9.99% | 0.65% | 3.10% | 8.11% |
| 20-Day Relative Strength | 42.11% | 37.48% | 36.64% | 27.91% | 36.90% |
| Weighted Alpha | +44.81 | -30.16 | +4.25 | -25.27 | +15.62 |
| Today's Opinion | 8% Buy | 72% Sell | 56% Sell | 100% Sell | 8% Buy |
| Previous Opinion | 8% Buy | 56% Sell | 56% Sell | 100% Sell | 8% Buy |
| Last Month's Opinion | 24% Buy | 24% Sell | 8% Sell | 88% Sell | 40% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -10.50% since 04/11/24 | -1.67% since 04/11/24 | -2.69% since 04/11/24 | -3.63% since 04/11/24 | -1.69% since 04/11/24 |
| Low | 37.62 on 04/18/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 42.01 on 04/12/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.62 on 04/12/24 | 402.49 on 04/15/24 |
| 1-Month | |||||
| %Chg | -6.13% since 03/18/24 | -6.38% since 03/18/24 | -3.01% since 03/18/24 | -9.69% since 03/18/24 | -4.35% since 03/18/24 |
| Low | 37.62 on 04/18/24 | 47.62 on 04/18/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 43.68 on 04/09/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 |
| 3-Month | |||||
| %Chg | -6.94% since 01/18/24 | -3.57% since 01/18/24 | -13.71% since 01/18/24 | -23.43% since 01/18/24 | -9.12% since 01/18/24 |
| Low | 37.62 on 04/18/24 | 47.58 on 02/06/24 | 262.58 on 04/18/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 |
| High | 52.57 on 02/12/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| 6-Month | |||||
| %Chg | +68.11% since 10/18/23 | -15.04% since 10/18/23 | -7.35% since 10/18/23 | -16.96% since 10/18/23 | +7.05% since 10/18/23 |
| Low | 21.34 on 10/24/23 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 |
| High | 52.57 on 02/12/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,312,383 | 96,960,152 | 141,520,144 | 83,333,008 | 101,600,240 |
| Shares Outstanding, K | 60,140 | 2,026,759 | 535,919 | 1,245,077 | 258,459 |
| Annual Sales | 77,430,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 |
| Annual Net Income | -184,680,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 |
| Last Quarter Sales | 24,230,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 |
| Last Quarter Net Income | -41,630,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 968,800,000 |
| 60-Month Beta | 1.90 | 0.39 | 0.58 | 0.19 | 0.35 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.70 on 02/22/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 |
| Latest Earnings Date | 05/07/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/06/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.43 | 14.24 | 10.02 | 29.33 |